Hyaluronan in breast cancer: Correlations with nitric oxide synthases and tyrosine nitrosylation

Journal of Histochemistry and Cytochemistry

Volumn 55, Issue 12, 2007, Pages 1191-1198

  Karihtala, Peeter ^a   Soini, Ylermi ^b,c   Auvinen, Päivi ^c   Tammi, Raija ^b   Tammi, Markku ^b   Kosma, Veli Matti ^b,c  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antioxidant enzymes; Hyaluronic acid; Nitric oxide; Nitric oxide synthases; Nitrotyrosine; Reactive oxygen species

Indexed keywords

3 NITROTYROSINE; ESTROGEN RECEPTOR; GLYCOSAMINOGLYCAN; HYALURONIC ACID; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROGESTERONE RECEPTOR; REACTIVE OXYGEN METABOLITE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN TISSUE; LYSOSOME; NITROSYLATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

ANTIOXIDANTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; STROMAL CELLS; TYROSINE;

EID: 36348973389     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.7A7270.2007     Document Type: Article

References (67)

1. Ågren UM, Tammi RH, Tammi MI (1997) Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture. Free Radic Biol Med 23:996-1001
2. Auvinen P, Tammi R, Parkkinen J, Tammi M, Ågren U, Johansson R, Hirvikoski P, et al. (2000) Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 156:529-536
3. Auvinen PK, Parkkinen JJ, Johansson RT, Ågren UM, Tammi RH, Eskelinen MJ, Kosma VM (1997) Expression of hyaluronan in benign and malignant breast lesions. Int J Cancer 74:477-481
4. Brown NS, Bicknell R (2001) Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res 3:323-327
5. Cadenas E (2004) Mitochondrial free radical production and cell signalling. Mol Aspects Med 25:17-26
6. Campo GM, Avenoso A, Campo S, D'Ascola A, Ferlazzo AM, Calatroni A (2004) Reduction of DNA fragmentation and hydroxyl radical production by hyaluronic acid and chondroitin-4-sulphate in iron plus ascorbate-induced oxidative stress in fibroblast cultures. Free Radic Res 38:601-611
7. Chazotte-Aubert L, Hainaut P, Ohshima H (2000) Nitric oxide nitrates tyrosine residues of tumor-suppressor p53 protein in MCF-7 cells. Biochem Biophys Res Commun 267:609-613
8. Chenevier-Gobeaux C, Morin-Robinet S, Lemarechal H, Poiraudeau S, Ekindjian JC, Borderie D (2004) Effects of pro- and anti-inflammatory cytokines and nitric oxide donors on hyaluronic acid synthesis by synovial cells from patients with rheumatoid arthritis. Clin Sci (Lond) 107:291-296
9. Corte MD, Gonzalez LO, Lamelas ML, Alvarez A, Junquera S, Allende MT, Garcia-Muniz JL, et al. (2006) Expression and clinical signification of cytosolic hyaluronan levels in invasive breast cancer. Breast Cancer Res Treat 97:329-337
10. Davis KL, Martin E, Turko IV, Murad F (2001) Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 41:203-236
11. Day AJ, de la Motte CA (2005) Hyaluronan cross-linking: a protective mechanism in inflammation? Trends Immunol 26:637-643
12. Delmage JM, Powars DR, Jaynes PK, Allerton SE (1986) The selective suppression of immunogenicity by hyaluronic acid. Ann Clin Lab Sci 16:303-310
13. Elston CW, Ellis IO (1998) Classification of malignant breast disease. In Elston CW, Ellis IO, eds. The Breast Systemic Pathology, vol. 13. Edinburgh, Churchill Livingstone, 239-247
14. Fjeldstad K, Kolset SO (2005) Decreasing the metastatic potential in cancers - targeting the heparan sulfate proteoglycans. Curr Drug Targets 6:665-682
15. Franzmann EJ, Schroeder GL, Goodwin WJ, Weed DT, Fisher P, Lokeshwar VB (2003) Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. Int J Cancer 106:438-445
16. Fraser JR, Laurent TC, Laurent UB (1997) Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242:27-33
17. Fukuda K, Takayama M, Ueno M, Oh M, Asada S, Kumano F, Tanaka S (1997) Hyaluronic acid inhibits interleukin-1-induced superoxide anion in bovine chondrocytes. Inflamm Res 46:114-117
18. Gasdaska PY, Oblong JE, Cotgreave IA, Powis G (1994) The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors. Biochim Biophys Acta 1218:292-296
19. Götte M, Yip GW (2006) Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66:10233-10237
20. Grogan TM, Fenoglio-Prieser C, Zeheb R, Bellamy W, Frutiger Y, Vela E, Stemmerman G, et al. (2000) Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival. Hum Pathol 31:475-481
21. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, Matalon S (1993) Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol 265:555-564
22. Hashimoto K, Fukuda K, Yamazaki K, Yamamoto N, Matsushita T, Hayakawa S, Munakata H, et al. (2006) Hypoxia-induced hyaluronan synthesis by articular chondrocytes: the role of nitric oxide. Inflamm Res 55:72-77
23. Heldin P, De La Torre M, Ytterberg D, Bergh J (1996) Differential synthesis and binding of hyaluronan by human breast cancer cell lines expressing different forms of CD44: relationship to hormone receptor status. Oncol Rep 3:1011-1016
24. Hiltunen EL, Anttila M, Kultti A, Ropponen K, Penttinen J, Yliskoski M, Kuronen AT, et al. (2002) Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors. Cancer Res 62:6410-6413
25. Huie RE, Padmaja S (1993) The reaction of no with superoxide. Free Radic Res Commun 18:195-199
26. Kahlos K, Soini Y, Säily M, Koistinen P, Kakko S, Pääkkö P, Homgren A, et al. (2001) Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma. Int J Cancer 95:198-204
27. Kalaci A, Yilmaz HR, Asian B, Sogut S, Yanat AN, Uz E (2007) Effects of hyaluronan on nitric oxide levels and superoxide dismutase activities in synovial fluid in knee osteoarthritis. Clin Rheumatol 25:1306-1311
28. Karatay S, Kiziltunc A, Yildirim K, Karanfil RC, Senel K (2005) Effects of different hyaluronic acid products on synovial fluid NO levels in knee osteoarthritis. Clin Rheumatol 24:497-501
29. Karihtala P, Kinnula VL, Soini Y (2004) Antioxidative response for nitric oxide production in breast carcinoma. Oncol Rep 12:755-759
30. Karihtala P, Mäntyniemi A, Kang SW, Kinnula VL, Soini Y (2003) Peroxiredoxins in breast carcinoma. Clin Cancer Res 9:3418-3424
31. Karihtala P, Winqvist R, Syväoja JE, Kinnula VL, Soini Y (2006) Increasing oxidative damage and loss of mismatch repair enzymes during breast carcinogenesis. Eur J Cancer 42:2653-2659
32. Kinnula VL, Crapo JD (2004) Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med 36:718-744
33. Klaunig JE, Xu Y, Isenberg JS, Bachowski S, Kolaja KL, Jiang J, Stevenson DE, et al. (1998) The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 106(suppl 1):289-295
34. Knudson W, Biswas C, Toole BP (1984) Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc Natl Acad Sci USA 81:6767-6771
35. Koyama H, Hibi T, Isogai Z, Yoneda M, Fujimori M, Amano J, Kawakubo M, et al. (2007) Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am J Pathol 170:1086-1099
36. Laurent TC, Fraser JR (1992) Hyaluronan. FASEB J 6:2397-2404
37. Lehtonen ST, Svensk AM, Soini Y, Pääkkö P, Hirvikoski P, Kang SW, Säily M, et al. (2004) Peroxiredoxins, a novel protein family in lung cancer. Int J Cancer 111:514-521
38. Lesley J, Hascall VC, Tammi M, Hyman R (2000) Hyaluronan binding by cell surface CD44. J Biol Chem 275:26967-26975
39. Li JJ, Oberley LW, St Clair DK, Ridnour LA, Oberley TD (1995b) Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene 10:1989-2000
40. Li Y, Huang T-T, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, et al. (1995a) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11:376-381
41. Li Y, Li L, Brown TJ, Heldin P (2007) Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Int J Cancer 120:2557-2567
42. Lincoln DT, Ali Emadi EM, Tonissen KF, Clarke FM (2003) The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res 23:2425-2433
43. Lipponen P, Aaltomaa S, Tammi R, Tammi M, Ågren U, Kosma V-M (2001) High stromal hyaluronan is associated with poor differentiation and metastasis in prostate cancer. Eur J Cancer 37: 849-856
44. Llaneza A, Vizoso F, Rodriguez JC, Raigoso P, Garcia-Muniz JL, Allende MT, Garcia-Moran M (2000) Hyaluronic acid as prognostic marker in resectable colorectal cancer. Br J Surg 87: 1690-1696
45. Nathan C, Xie QW (1994) Regulation of biosynthesis of nitric oxide. J Biol Chem 269:13725-13728
46. Paiva P, Van Damme MP, Tellbach M, Jones RL, Jobling T, Salamonsen LA (2005) Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Gynecol Oncol 98:193-202
47. Posey JT, Soloway MS, Ekici S, Sofer M, Civantos F, Duncan RC, Lokeshwar VB (2003) Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer. Cancer Res 63:2638-2644
48. Radi R, Peluffo G, Alvarez MN, Naviliat M, Cayota A (2001) Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 30:463-488
49. Radi R, Rodriguez M, Castro L, Telleri R (1994) Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 308:89-95
50. Ricciardelli C, Russell DL, Ween MP, Suwiwat S, Byers S, Marshall VR, Tilley WD, et al. (2007) Formation of hyaluronan-and versican-rich pericellular matrix by prostate cancer cells promotes cell motility. J Biol Chem 282:10814-10825
51. Rooney P, Kumar S, Ponting J, Wang M (1995) The role of hyaluronan in tumour neovascularization (review). Int J Cancer 60:632-636
52. Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R, Lipponen P, Ågren U, et al. (1998) Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 58:342-347
53. Setälä LP, Tammi MI, Tammi RH, Eskelinen MJ, Lipponen PK, Ågren UM, Parkkinen J, et al. (1999) Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer 79:1133-1138
54. Soini Y, Vakkala M, Kahlos K, Pääkkö P, Kinnula V (2001) MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells. J Pathol 195:156-162
55. Sokes L, Mendichi R, Kogan G, Schiller J, Stankovska M, Arnhold J (2006) Degradative action of reactive oxygen species on hyaluronan. Biomacromolecules 7:659-668
56. Stern R (2005) Hyaluronan metabolism: a major paradox in cancer biology. Pathol Biol (Paris) 53:372-382
57. Suwiwat S, Ricciardelli C, Tammi R, Tammi M, Auvinen P, Kosma VM, LeBaron RG, et al. (2004) Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res 10:2491-2498
58. Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51:794-798
59. Takahashi K, Hashimoto S, Kubo T, Hirasawa Y, Lotz M, Amiel D (2001) Hyaluronan suppressed nitric oxide production in the meniscus and synovium of rabbit osteoarthritis model. J Orthop Res 19:500-503
60. Tammi R, Ågren UM, Tuhkanen AL, Tammi M (1994) Hyaluronan metabolism in skin. Prog Histochem Cytochem 29:1-81
61. Tavassoli FA, Devilee P, eds (2003) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France, IARC Press
62. Toole BP (2002) Hyaluronan promotes the malignant phenotype. Glycobiology 12:37R-42R
63. Toyokuni S, Okamoto K, Yodoi J, Hiai H (1995) Persistent oxidative stress in cancer. FEBS Lett 358:1-3
64. Vizoso FJ, del Casar JM, Corte MD, Garcia I, Corte MG, Alvarez A, Garcia-Muniz JL (2004) Significance of cytosolic hyaluronan levels in gastric cancer. Eur J Surg Oncol 30:318-324
65. Wernicke M, Pineiro LC, Caramutti D, Dorn VG, Raffo MM, Guixa HG, Telenta M, et al. (2003) Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan. Mod Pathol 16:99-107
66. Wiseman H, Halliwell B (1996) Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313:17-29
67. Yoshihara S, Kon A, Kudo D, Nakazawa H, Kakizaki I, Sasaki M, Endo M, et al. (2005) A hyaluronan synthase suppressor, 4-methylumbelliferone, inhibits liver metastasis of melanoma cells. FEBS Lett 579:2722-2726